acc2351 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Breast Cancer |
MDA-MB-468 |
Vinorelbine |
Associated |
4.0 (Moderate) |
20693278
|
acc2352 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Breast Cancer |
MDA-MB-468 |
Paclitaxel |
Associated |
4.0 (Moderate) |
20693278
|
acc2353 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Prostate Cancer |
DU145 |
Vinorelbine |
Associated |
4.0 (Moderate) |
20693278
|
acc2354 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Prostate Cancer |
DU145 |
Paclitaxel |
Associated |
4.0 (Moderate) |
20693278
|
acc2355 |
STAT3 |
phosphorylation |
Ser727 |
human |
Breast Cancer |
MDA-MB-468 |
Vinorelbine |
Associated |
4.0 (Moderate) |
20693278
|
acc2356 |
STAT3 |
phosphorylation |
Ser727 |
human |
Breast Cancer |
MDA-MB-468 |
Paclitaxel |
Associated |
4.0 (Moderate) |
20693278
|
acc2357 |
STAT3 |
phosphorylation |
Ser727 |
human |
Breast Cancer |
BT549 |
Vinorelbine |
Associated |
4.0 (Moderate) |
20693278
|
acc2358 |
STAT3 |
phosphorylation |
Ser727 |
human |
Breast Cancer |
BT549 |
Paclitaxel |
Associated |
4.0 (Moderate) |
20693278
|
acc2359 |
STAT3 |
phosphorylation |
Ser727 |
human |
Breast Cancer |
MCF7 |
Vinorelbine |
Associated |
4.0 (Moderate) |
20693278
|
acc2360 |
STAT3 |
phosphorylation |
Ser727 |
human |
Breast Cancer |
MCF7 |
Paclitaxel |
Associated |
4.0 (Moderate) |
20693278
|
acc2361 |
STAT3 |
phosphorylation |
Ser727 |
human |
Ovarian Cancer |
OVCAR8 |
Vinorelbine |
Associated |
4.0 (Moderate) |
20693278
|
acc2362 |
STAT3 |
phosphorylation |
Ser727 |
human |
Ovarian Cancer |
OVCAR8 |
Paclitaxel |
Associated |
4.0 (Moderate) |
20693278
|
acc2363 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Breast Cancer |
BT549 |
Vinorelbine |
Associated |
4.0 (Moderate) |
20693278
|
acc2364 |
STAT3 |
phosphorylation |
Ser727 |
human |
Ovarian Cancer |
SK-OV-3 |
Vinorelbine |
Associated |
4.0 (Moderate) |
20693278
|
acc2365 |
STAT3 |
phosphorylation |
Ser727 |
human |
Ovarian Cancer |
SK-OV-3 |
Paclitaxel |
Associated |
4.0 (Moderate) |
20693278
|
acc2366 |
STAT3 |
phosphorylation |
Ser727 |
human |
Prostate Cancer |
DU145 |
Vinorelbine |
Associated |
4.0 (Moderate) |
20693278
|
acc2367 |
STAT3 |
phosphorylation |
Ser727 |
human |
Prostate Cancer |
DU145 |
Paclitaxel |
Associated |
4.0 (Moderate) |
20693278
|
acc2368 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Breast Cancer |
BT549 |
Paclitaxel |
Associated |
4.0 (Moderate) |
20693278
|
acc2369 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Breast Cancer |
MCF7 |
Vinorelbine |
Associated |
4.0 (Moderate) |
20693278
|
acc2370 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Breast Cancer |
MCF7 |
Paclitaxel |
Associated |
4.0 (Moderate) |
20693278
|
acc2371 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Ovarian Cancer |
OVCAR8 |
Vinorelbine |
Associated |
4.0 (Moderate) |
20693278
|
acc2372 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Ovarian Cancer |
OVCAR8 |
Paclitaxel |
Associated |
4.0 (Moderate) |
20693278
|
acc2373 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Ovarian Cancer |
SK-OV-3 |
Vinorelbine |
Associated |
4.0 (Moderate) |
20693278
|
acc2374 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Ovarian Cancer |
SK-OV-3 |
Paclitaxel |
Associated |
4.0 (Moderate) |
20693278
|
acc2375 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Liver Cancer |
HepG2 |
Bazedoxifene |
Associated |
4.0 (Moderate) |
30648776
|
acc2376 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Liver Cancer |
SSMC-7721 |
Bazedoxifene |
Associated |
4.0 (Moderate) |
30648776
|
acc2377 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Liver Cancer |
HuH-7 |
Bazedoxifene |
Associated |
4.0 (Moderate) |
30648776
|
acc2378 |
STAT3 |
phosphorylation |
Ser727 |
human |
Prostate Cancer |
DU145 |
Scoparone |
Associated |
4.0 (Moderate) |
24260381
|
acc2379 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Prostate Cancer |
DU145 |
Scoparone |
Associated |
4.0 (Moderate) |
24260381
|
acc2380 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Ovarian Cancer |
SK-OV-3 |
Bazedoxifene + SCH527123 |
Associated |
4.0 (Moderate) |
35315502
|
acc2381 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
SK-OV-3 |
Bazedoxifene + SCH527123 |
Associated |
4.0 (Moderate) |
35315502
|
acc2382 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Ovarian Cancer |
CAOV3 |
Bazedoxifene + SCH527123 |
Associated |
4.0 (Moderate) |
35315502
|
acc2383 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
CAOV3 |
Bazedoxifene + SCH527123 |
Associated |
4.0 (Moderate) |
35315502
|
acc2384 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Ovarian Cancer |
OVCAR-3 |
Bazedoxifene + SCH527123 |
Associated |
4.0 (Moderate) |
35315502
|
acc2385 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
OVCAR-3 |
Bazedoxifene + SCH527123 |
Associated |
4.0 (Moderate) |
35315502
|
acc2386 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Ovarian Cancer |
OV75 |
Bazedoxifene + SCH527123 |
Associated |
4.0 (Moderate) |
35315502
|
acc2387 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
OV75 |
Bazedoxifene + SCH527123 |
Associated |
4.0 (Moderate) |
35315502
|
acc2388 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Ovarian Cancer |
SK-OV-3TR(paclitaxel-res) |
CDDO-Me |
Associated |
4.0 (Moderate) |
18587580
|
acc2389 |
JAK2 |
phosphorylation |
Tyr1007 |
human |
Ovarian Cancer |
SK-OV-3TR(paclitaxel-res) |
CDDO-Me |
Associated |
4.0 (Moderate) |
18587580
|
acc2390 |
JAK2 |
phosphorylation |
Tyr1008 |
human |
Ovarian Cancer |
SK-OV-3TR(paclitaxel-res) |
CDDO-Me |
Associated |
4.0 (Moderate) |
18587580
|
acc2391 |
Src |
phosphorylation |
Tyr530 |
human |
Ovarian Cancer |
SK-OV-3TR(paclitaxel-res) |
CDDO-Me |
Associated |
4.0 (Moderate) |
18587580
|
acc2392 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Leukemia |
K562 |
Cryptotanshinone |
Associated |
4.0 (Moderate) |
30054832
|
acc2393 |
STAT5 |
phosphorylation |
Tyr694 |
human |
Leukemia |
|
Cryptotanshinone |
Associated |
4.0 (Moderate) |
30054832
|
acc2394 |
STAT5 |
phosphorylation |
Tyr694 |
human |
Leukemia |
|
Imatinib mesylate |
Associated |
4.0 (Moderate) |
28387753
|
acc2395 |
STAT5 |
phosphorylation |
Tyr694 |
human |
Breast Cancer |
HC11-Cuzd1 |
Pimozide |
Associated |
4.0 (Moderate) |
29321207
|
acc2396 |
STAT5 |
phosphorylation |
Tyr694 |
human |
Breast Cancer |
MCF7-Cuzd1 |
Pimozide |
Associated |
4.0 (Moderate) |
29321207
|
acc2397 |
STAT5 |
phosphorylation |
Tyr694 |
human |
Lymphoma |
CRL-2105 |
Romidepsin |
Impairing |
5.0 (High)
|
34089720
|
acc2398 |
STAT5 |
phosphorylation |
Tyr694 |
human |
Lymphoma |
HuT78 |
Romidepsin |
Impairing |
5.0 (High)
|
34089720
|
acc2399 |
STAT5 |
phosphorylation |
Tyr694 |
human |
Hepatocellular Carcinoma |
|
PD-1 therapy |
Impairing |
4.5 (High)
|
34036623
|
acc2400 |
STAT6 |
phosphorylation |
Tyr641 |
mouse |
Breast Cancer |
4T1 |
Emodin |
Associated |
4.0 (Moderate) |
25311112
|